Delivery Order SPE2DB22D1017-SPE2DB25FG4DG

Award Date 6/3/25
Potential Completion Date 6/4/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,383.36 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. This contract is for the delivery of 4,563,172,594 units of the prescription medication Depakote DR 250 mg tablets. The contract has a completion date of December 26, 2023 and uses a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,207.01 firm fixed-price delivery order is for the supply of 4,568,106,903 units of the medication Depakote DR 125 mg sprinkle capsules. The contract has a performance period through May 2, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,090.64, is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA. The IDC, worth up to $999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,582.63, is a Firm Fixed Price Delivery Order for 4567854243 ! DEPAKOTE DR 125 MG SPRINKLE CP 100S. The contract has an ultimate completion date of April 10, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Depakote DR 125 mg sprinkle capsules, a neurological medication. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $1,787.78 and an ultimate completion date of May 21, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a $1,147.13 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DEPAKOTE DR 125 MG SPRINKLE CP 100S, a generic pharmaceutical product. The contract has an ultimate completion date of April 8, 2025 and does not utilize any set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Depakote DR 125 mg sprinkle capsules, with a ceiling value of $1,824.98 and a period of performance through May 1, 2025. The contract is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,150.56 firm fixed-price contract is for the supply of 4,568,239,064 units of the prescription medication Divalproex Sodium Extended-Release 500 mg Tablets. The award is not set aside and represents an order under Amerisourcebergen's existing $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, valued at $1,276.08. The contract is for the delivery of Depakote ER 250 mg tablets, a medication used to treat certain types of seizures and mental health conditions. The contract is a firm fixed-price, delivery order type with a period of performance ending on November 13, 2024. This award is not associated with a set-aside program....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,124.64 firm fixed-price contract is for the supply of various pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and antibiotics. The contract has an...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FG4DG
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is a delivery order valued at $2,227.26 for the provision of 4,568,439,684 Depakote DR 500 MG tablets. The contract is a firm fixed-price, non-set-aside award with a completion date of June 4, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 9/2/25, 9:56 AM